Impact of first-line FOLFIRINOX versus Gemcitabine/Nab-Paclitaxel chemotherapy on survival in advanced pancreatic cancer: Evidence from the prospective international multicentre PURPLE pancreatic cancer registry-Reference-Cited by-同舟云学术

Impact of first-line FOLFIRINOX versus Gemcitabine/Nab-Paclitaxel chemotherapy on survival in advanced pancreatic cancer: Evidence from the prospective international multicentre PURPLE pancreatic cancer registry

Published:2022-10 Issue: Volume:174 Page:102-112
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Santucci Jordan,Tacey Mark,Thomson Benjamin,Michael Michael,Wong Rachel^ORCID,Shapiro Julia,Jennens Ross^ORCID,Clarke Kate,Pattison Sharon^ORCID,Burge Matthew,Zielinski Rob,Nikfarjam Mehrdad,Ananda Sumitra,Lipton Lara,Gibbs Peter^ORCID,Lee Belinda^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference20 articles.

1. The global burden of pancreatic cancer;Lippi;Arch Med Sci,2020

2. Pancreatic cancer;Kamisawa;Lancet,2016

3. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine;Von Hoff;N Engl J Med,2013

4. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer;Conroy;N Engl J Med,2011

5. Advanced pancreatic cancer: a meta-analysis of clinical trials over thirty years;Hall;Oncotarget,2018

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plasma miR-379 can predict treatment response to FOLFIRINOX and gemcitabine-nab-paclitaxel in advanced pancreatic cancer;The Journal of Liquid Biopsy;2024-09

2. Outcomes After Multimodality Treatment of Pancreatic Cancer in an Unselected Single-Center Cohort;Cancer Management and Research;2024-08

3. Enhancing Neoadjuvant Virotherapy’s Effectiveness by Targeting Stroma to Improve Resectability in Pancreatic Cancer;Biomedicines;2024-07-18

4. Head‐to‐head comparison of treatment sequences in advanced pancreatic cancer—Real‐world data from the prospective German TPK clinical cohort study;International Journal of Cancer;2024-07-02

5. Improving Clinical Registry Data Quality via Linkage With Survival Data From State-Based Population Registries;JCO Clinical Cancer Informatics;2024-06